ADVFN US – Market Content Editor
-

Agnico Eagle Shares Fall 4.9% as Gold Prices Decline
Agnico Eagle (NYSE:AEM) shares fell 4.9% to $184.99 in pre-open trading as gold prices declined during Monday’s session. Spot gold fell below $4,200 per ounce intraday, representing a decline of more than $100 during the session. The move in gold came as comments from several Federal Reserve officials contributed to expectations for an additional 25-basis-point…
-

MongoDB Shares Fall 15% as CEO Chirantan Desai Resigns to Join Meta
MongoDB (NASDAQ:MDB) shares fell 15% on Monday after President and Chief Executive Officer Chirantan “CJ” Desai resigned with immediate effect to take a newly created role at Meta Platforms (NASDAQ). Desai will become Meta’s Chief Enterprise Platform Officer, reporting directly to Chief Executive Officer Mark Zuckerberg. Following Desai’s departure, MongoDB appointed former CEO Dev Ittycheria…
-

AbbVie Receives FDA Approval for Parkinson’s Disease Drug Juvmo
AbbVie Inc (NYSE:ABBV) received approval from the U.S. Food and Drug Administration for Juvmo, or tavapadon, tablets for the treatment of Parkinson’s disease. According to the company, Juvmo is the first and only selective D1/D5 receptor agonist approved for the indication. Approval Based on Phase 3 TEMPO Program The FDA approval was supported by results…
-

Gold Fields Shares Fall 13.5% After Northern Star Rejects Takeover Proposal
Gold Fields Ltd ADR (NYSE:GFI) shares fell 13.5% in pre-open trading after Northern Star Resources rejected an unsolicited A$38.7 billion, or approximately $27.1 billion, takeover proposal from the South African gold producer. Northern Star’s board unanimously rejected the proposal and indicated on September 24, 2026, that further discussions were not appropriate at that time. Gold…
-

Copper Falls to Lowest Level in More Than a Week After China Data
Copper prices declined to their lowest level in more than a week on Monday as weaker economic data from China and a stronger US dollar affected expectations for demand. Benchmark copper on the London Metal Exchange fell 1.8% to $14,364 per metric ton at 09:13 GMT. Prices earlier reached $14,354 per metric ton, their lowest…
-

US Stock Futures Point Lower as Crude Oil Prices Rebound: Dow Jones, S&P, Nasdaq, Wall Street
US stock futures pointed to a lower opening on Monday as crude oil prices rebounded following developments involving Iran and the Strait of Hormuz. US crude oil futures rose 2.6% after declining 2.3% on Friday, when reports emerged of an Iranian proposal concerning a ceasefire and the reopening of the Strait of Hormuz. President Donald…
-

Boeing Shares Fall After Report of 737 MAX Software Issue
Boeing (NYSE:BA) shares fell 1.9% after The Wall Street Journal reported that the planemaker had identified a software issue affecting an automated navigation function on the 737 MAX. According to the report, the software issue can disable the automated navigation function during a landing following a missed approach. The issue emerged following an update to…
-

Circle Internet Group Shares Fall After CFO Announces Departure
Circle Internet Group (NYSE:CRCL) shares fell 3.5% after the company announced that Chief Financial Officer Jeremy Fox-Geen plans to step down following more than five years in the role. Fox-Geen will remain with Circle through the end of December 2026 to assist with the transition. The company has engaged an executive search firm to help…
-

TruGolf Announces Reverse Stock Split and Leadership Changes
TruGolf Holdings, Inc. (NASDAQ:TRUG) announced a series of corporate developments during September, including a reverse stock split and management changes, as the company continues work on its proposed acquisition of Polymath Research Inc. Founder Chris Jones resigned as chief executive officer, while Chairman Brenner Adams was appointed interim CEO. TruGolf also appointed Jay Heller to…
-

Adicet Bio Reports Phase 1 Prula-cel Data in Lupus Patients
Adicet Bio, Inc. (NASDAQ:ACET) reported Phase 1 clinical data for prulacabtagene leucel, or prula-cel, its investigational allogeneic gamma delta CAR-T cell therapy, in patients with systemic lupus erythematosus with or without lupus nephritis. The data cutoff was August 28, 2026, and included 22 efficacy-evaluable patients, comprising 16 with lupus nephritis and six with extra-renal systemic…